CD8A and neoplasm: Additionally, peripheral CD8+ T-cell counts, CD3+ T-cell counts, CD19+ B-cell counts, and CD4/CD8 ratio all showed relationships with tumor response to carbon ion radiotherapy in patients with prostate cancer [25].